UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 8, 2017 4:00 P.M.

Form:	S-1
CIK: 0001492422 Company Name: Apellis Pharmaceuticals, Inc. File Number: 333-220941